Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961 · see citing works

Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902 · see citing works

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550 · see citing works

AHA Dietary Guidelines: Revision 2000: A Statement for Healthcare Professionals From the Nutrition Committee of the American Heart Association

Krauss, R. M., Eckel, R. H., Howard, B., Appel, L. J., Daniels, S. R., Deckelbaum, R. J., Erdman, J. W., Kris-Etherton, P., Goldberg, I. J., Kotchen, T. A., et al. (2000) · Circulation · doi:10.1161/01.cir.102.18.2284 · Cited by 1,458 · see citing works

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

Nakajima, K., SAITO, T., Tamura, A., Suzuki, M., Nakano, T., Adachi, M., Tanaka, A., Tada, N., Nakamura, H., Campos, E. M., et al. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90062-9 · Cited by 417 · see citing works

Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.

PHILLIPS, N. R., Waters, D. D., & Havel, R. J. (1993) · Circulation · doi:10.1161/01.cir.88.6.2762 · Cited by 345 · see citing works

Beyond Low-Density Lipoprotein Cholesterol

Arsenault, B. J., Rana, J. S., Stroes, E. S. G., Després, J.-P., Shah, P. K., Kastelein, J. J. P., Wareham, N. J., Boekholdt, S. M., & Khaw, K.-T. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.057 · Cited by 342 · see citing works

Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study

McNamara, J. R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00484-6 · Cited by 278 · see citing works

Remnant Lipoproteins Induce Proatherothrombogenic Molecules in Endothelial Cells Through a Redox-Sensitive Mechanism

Doi, H., Kugiyama, K., Oka, H., Sugiyama, S., Ogata, N., Koide, S.-I., Nakamura, S.-I., & Yasue, H. (2000) · Circulation · doi:10.1161/01.cir.102.6.670 · Cited by 227 · see citing works

Elevated Remnant-Like Particle Cholesterol Concentration: A Characteristic Feature of the Atherogenic Lipoprotein Phenotype

Twickler, T. B., Dallinga-Thie, G. M., Cohn, J. S., & Chapman, M. J. (2004) · Circulation · doi:10.1161/01.cir.0000125278.58527.f3 · Cited by 201 · see citing works

Association of Remnant Lipoprotein Levels With Impairment of Endothelium-Dependent Vasomotor Function in Human Coronary Arteries

Kugiyama, K., Doi, H., Motoyama, T., Soejima, H., Misumi, K., Kawano, H., Nakagawa, O., Yoshimura, M., Ogawa, H., Matsumura, T., et al. (1998) · Circulation · doi:10.1161/01.cir.97.25.2519 · Cited by 187 · see citing works

Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes

Ray, K. K., Cannon, C. P., Cairns, R., Morrow, D. A., Ridker, P. M., & D, E. B. M. (2009) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.108.181735 · Cited by 155 · see citing works

Beyond Low-Density Lipoprotein Cholesterol

Mudd, J. O., Borlaug, B. A., Johnston, P. V., Kral, B. G., Rouf, R., Blumenthal, R. S., & Kwiterovich, P. O. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.07.045 · Cited by 136 · see citing works

Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation

Royston, P. J., & Sauerbrei, W. (2003) · Statistics in Medicine · doi:10.1002/sim.1310 · Cited by 121 · see citing works

Remnant lipoproteins as therapeutic targets

Havel, R. J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00008 · Cited by 107 · see citing works

Statin Therapy Alters the Relationship Between Apolipoprotein B and Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Targets in High-Risk Patients

Ballantyne, C. M., Raichlen, J. S., & Cain, V. A. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.052 · Cited by 102 · see citing works

Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart Disease

Miller, M., Ginsberg, H. N., & Schaefer, E. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.046 · Cited by 102 · see citing works

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus

Fukushima, H., Sugiyama, S., Honda, O., Koide, S., Nakamura, S., Sakamoto, T., Yoshimura, M., Ogawa, H., Fujioka, D., & Kugiyama, K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.074 · Cited by 91 · see citing works

Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome.

Nakamura, T., Takano, H., Umetani, K., Kawabata, K.-I., Obata, J.-E., Kitta, Y., Kodama, Y., Mende, A., Ichigi, Y., Fujioka, D., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.012 · Cited by 90 · see citing works

Are Remnant-Like Particles Independent Predictors of Coronary Heart Disease Incidence?

Imke, C., Rodríguez, B. L., Grove, J., McNamara, J. R., Waslien, C., Katz, A. R., Willcox, B. J., Yano, K., & Curb, J. D. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000173310.85845.7b · Cited by 89 · see citing works

Heterogeneity of very-low-density lipoprotein metabolism in hyperlipidemic subjects

Nestel, P. J., Billington, T., Tada, N., Nugent, P., & Fidge, N. (1983) · Metabolism · doi:10.1016/0026-0495(83)90112-9 · Cited by 65 · see citing works

Triglyceride-rich lipoproteins and progression of atherosclerosis.

Hodis, H. N., & Mack, W. J. (1998) · PubMed · Cited by 51 · see citing works

Comparison of remnant-like lipoprotein particles in postmenopausal women with and without coronary artery disease and in men with coronary artery disease

Fukushima, H., Kugiyama, K., Sugiyama, S., Honda, O., Koide, S.-I., Nakamura, S.-I., Kawano, H., Soejima, H., Miyamoto, S., Yoshimura, M., et al. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(01)02115-4 · Cited by 44 · see citing works

Influence of intermediate-density lipoproteins on the accuracy of the Friedewald formula

Sentı́, M., Pedro‐Botet, J., Nogués, X., & Rubiés-Prat, J. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.8.1394 · Cited by 36 · see citing works

High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis

Nakamura, T., Obata, J., Takano, H., Kawabata, K., Sano, K., Kobayashi, T., Fujioka, D., Saitō, Y., Yano, T., & Kugiyama, K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.018 · Cited by 35 · see citing works

Expert Perspective: Reducing Cardiovascular Risk in Metabolic Syndrome and Type 2 Diabetes Mellitus Beyond Low-Density Lipoprotein Cholesterol Lowering

Jones, P. H. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.09.074 · Cited by 32 · see citing works

High Plasma Level of Remnant-Like Particles Cholesterol in Familial Combined Hyperlipidemia

Graaf, J. D., van der Vleuten, G. M., ter Avest, E., Dallinga‐Thie, G. M., & Stalenhoef, A. F. H. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1973 · Cited by 26 · see citing works

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 317 · see citing works

Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook

Raja, V., Aguíar, C., Al-Sayed, N., Chibber, Y. S., ElBadawi, H., Владиславович, Е. М., Hermans, M. P., Pandey, R. C., Ray, K. K., Tokgözoğlu, L. S., et al. (2023) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2023.117312 · Cited by 217 · see citing works

Postprandial hypertriglyceridemia as a coronary risk factor

Borén, J., Matikainen, N., Adiels, M., & Taskinen, M.-R. (2014) · Clinica Chimica Acta · doi:10.1016/j.cca.2014.01.015 · Cited by 182 · see citing works

Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study

Quispe, R., Manalac, R. J., Faridi, K. F., Blaha, M. J., Toth, P. P., Kulkarni, K. R., Nasir, K., Virani, S. S., Banach, M., Blumenthal, R. S., et al. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.06.057 · Cited by 172 · see citing works

Lipids in Atherosclerosis: Pathophysiology and the Role of Calculated Lipid Indices in Assessing Cardiovascular Risk in Patients with Hyperlipidemia

Gaggini, M., Gorini, F., & Vassalle, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010075 · Cited by 183 · see citing works

Effect of a Moderate Fat Diet With and Without Avocados on Lipoprotein Particle Number, Size and Subclasses in Overweight and Obese Adults: A Randomized, Controlled Trial

Wang, L., Bordi, P. L., Fleming, J. A., Hill, A. M., & Kris‐Etherton, P. M. (2015) · Journal of the American Heart Association · doi:10.1161/jaha.114.001355 · Cited by 128 · see citing works

The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes

Cao, Y., Zhang, H., Jin, J., Liu, H., Zhang, Y., Gao, Y., Guo, Y., Wu, N., Hua, Q., Li, Y., et al. (2020) · Cardiovascular Diabetology · doi:10.1186/s12933-020-01076-7 · Cited by 98 · see citing works

Early initiation of eicosapentaenoic acid and statin treatment is associated with better clinical outcomes than statin alone in patients with acute coronary syndromes: 1-year outcomes of a randomized controlled study

Nosaka, K., Miyoshi, T., Iwamoto, M., Kajiya, M., Okawa, K., Tsukuda, S., Yokohama, F., Sogo, M., Nishibe, T., Matsuo, N., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.105 · Cited by 88 · see citing works

Remnant Cholesterol and Common Carotid Artery Intima-Media Thickness in Patients With Ischemic Stroke

Qian, S., You, S., Sun, Y., Wu, Q., Wang, X., Tang, W., Dong, X., Liu, C.-F., Xu, T., Cao, Y., et al. (2021) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.120.010953 · Cited by 86 · see citing works

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk

Baratta, F., Cocomello, N., Coronati, M., Ferro, D., Pastori, D., Angelico, F., & Ben, M. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054268 · Cited by 84 · see citing works

Chylomicrons: Advances in biology, pathology, laboratory testing, and therapeutics

Julve, J., Martín-Campos, J. M., Escolá‐Gil, J. C., & Blanco‐Vaca, F. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.02.004 · Cited by 85 · see citing works

Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol

Goliasch, G., Wiesbauer, F., Blessberger, H., Demyanets, S., Wojta, J., Huber, K., Maurer, G., Schillinger, M., & Speidl, W. S. (2015) · Journal of clinical lipidology · doi:10.1016/j.jacl.2015.08.009 · Cited by 67 · see citing works

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease

Pastori, D., Baratta, F., Novo, M., Cocomello, N., Violi, F., Angelico, F., & Ben, M. D. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110378 · Cited by 59 · see citing works

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies

Ballantyne, C. M., Bays, H. E., Philip, S., Doyle, R. T., Braeckman, R. A., Stirtan, W. G., Soni, P. N., & Juliano, R. A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.005 · Cited by 52 · see citing works

The relation between VLDL-cholesterol and risk of cardiovascular events in patients with manifest cardiovascular disease

Heidemann, B. E., Koopal, C., Bots, M. L., Asselbergs, F. W., Westerink, J., & Visseren, F. L. J. (2020) · International Journal of Cardiology · doi:10.1016/j.ijcard.2020.08.030 · Cited by 46 · see citing works

Comparing different assessments of remnant lipoprotein cholesterol: The very large database of lipids

Faridi, K. F., Quispe, R., Martin, S. S., Hendrani, A. D., Joshi, P. H., Brinton, E. A., Cruz, D. E., Banach, M., Toth, P. P., Kulkarni, K. R., et al. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.06.001 · Cited by 45 · see citing works

A comparison of the efficacy of combined ezetimibe and statin therapy with doubling of statin dose in patients with remnant lipoproteinemia on previous statin therapy

Nakamura, T., Hirano, M., Kitta, Y., Fujioka, D., Saitō, Y., Kawabata, K., Obata, J., Watanabe, Y., Watanabe, K., & Kugiyama, K. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.02.005 · Cited by 41 · see citing works

Association between remnant lipoprotein cholesterol levels and non-alcoholic fatty liver disease in adolescents

Chin, J., Mori, T. A., Adams, L. A., Beilin, L. J., Huang, R., Olynyk, J. K., & Ayonrinde, O. T. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100150 · Cited by 41 · see citing works

High-dose statin therapy with rosuvastatin reduces small dense LDL and MDA-LDL: The Standard versus high-dose therApy with Rosuvastatin for lipiD lowering (SARD) trial

Nishikido, T., Oyama, J., Keida, T., Ohira, H., & Node, K. (2015) · Journal of Cardiology · doi:10.1016/j.jjcc.2015.05.017 · Cited by 40 · see citing works

Atherogenic Lipoproteins in Subclinical Hypothyroidism and Their Relationship with Hepatic Lipase Activity: Response to Replacement Treatment with Levothyroxine

Brenta, G., Berg, G. A., Miksztowicz, V., Lopez, G. I., Lucero, D., Faingold, C., Murakami, M., Machima, T., Nakajima, K., & Schreier, L. E. (2016) · Thyroid · doi:10.1089/thy.2015.0140 · Cited by 36 · see citing works

Plasma Lipoprotein(a) Levels Are Associated with Mild Renal Impairment in Type 2 Diabetics Independent of Albuminuria

Lin, J. J., Reilly, M. P., Terembula, K., & Wilson, F. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114397 · Cited by 36 · see citing works

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk

Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113499 · Cited by 35 · see citing works

High Remnant Lipoprotein Predicts Recurrent Cardiovascular Events on Statin Treatment After Acute Coronary Syndrome

Nguyen, S. V., Nakamura, T., & Kugiyama, K. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0380 · Cited by 34 · see citing works

Effect of the Probiotic Saccharomyces boulardii on Cholesterol and Lipoprotein Particles in Hypercholesterolemic Adults: A Single-Arm, Open-Label Pilot Study

Ryan, J. J., Hanes, D. A., Schafer, M., Mikolai, J., & Zwickey, H. L. (2015) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2014.0063 · Cited by 34 · see citing works

Remnant lipoproteinemia predicts cardiovascular events in patients with type 2 diabetes and chronic kidney disease

Nguyen, S. V., Nakamura, T., Uematsu, M., Fujioka, D., Watanabe, K., Watanabe, Y., Obata, J.-E., Nakamura, K., & Kugiyama, K. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2016.04.011 · Cited by 33 · see citing works

Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies

Galli, M., Abbate, A., Bonaca, M. P., Crea, F., Forte, M., Frati, G., Gaudino, M. F. L., Gibson, C. M., Gorog, D. A., Mehran, R., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01249-z · Cited by 35 · see citing works

Predominance of large VLDL particles in metabolic syndrome, detected by size exclusion liquid chromatography

Lucero, D., Zago, V., López, G. H., Cacciagiú, L. D., Lopez, G. I., Wikinski, R. L. W., Nakajima, K., & Schreier, L. E. (2012) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2011.12.013 · Cited by 30 · see citing works

Improvement of endothelial dysfunction is mediated through reduction of remnant lipoprotein after statin therapy in patients with coronary artery disease

Nakamura, T., Uematsu, M., Yoshizaki, T., Kobayashi, T., Watanabe, Y., & Kugiyama, K. (2019) · Journal of Cardiology · doi:10.1016/j.jjcc.2019.08.006 · Cited by 29 · see citing works

Remnant cholesterol in atherosclerotic cardiovascular disease: A systematic review and meta-analysis

Delialis, D., Georgiopoulos, G. A., Aivalioti, E., Konstantaki, C., Oikonomou, E., Bampatsias, D., Mavraganis, G., Vardavas, C. I., Liberopoulos, E. N., Stellos, K., et al. (2023) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2023.04.007 · Cited by 31 · see citing works

Comparison of remnant cholesterol levels estimated by calculated and measured LDL-C levels in Chinese patients with coronary heart disease

Xiang, Q., Tian, F., Lin, Q., Du, X., Zhang, S., Gui, Y., Guo, L., Xu, J. R., Zhu, L., Wen, T., et al. (2019) · Clinica Chimica Acta · doi:10.1016/j.cca.2019.09.020 · Cited by 26 · see citing works

Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease

Li, X., Li, Z.-F., & Wu, N. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25985 · Cited by 26 · see citing works

A framework for exploring environmental risk of the longest inter-basin water diversion project under the influence of multiple factors: A case study in China

Zhang, C., Nong, X., Zhong, H., Shao, D., Chen, L., & Liang, J. (2022) · Journal of Environmental Management · doi:10.1016/j.jenvman.2022.116036 · Cited by 23 · see citing works

Nomogram to predict the risk and survival of synchronous bone metastasis in colorectal cancer: a population-based real-world analysis

Han, L., Dai, W., Mo, S., Xiang, W., Li, Q., Xu, Y., Wang, R., & Cai, G. (2020) · International Journal of Colorectal Disease · doi:10.1007/s00384-020-03612-z · Cited by 22 · see citing works

Remnant cholesterol and risk of myocardial infarction in patients with coronary artery disease undergoing revascularization

Zafrir, B., Khoury, R., & Saliba, W. (2023) · Journal of clinical lipidology · doi:10.1016/j.jacl.2023.03.009 · Cited by 20 · see citing works

Association of triglyceride-rich lipoprotein-cholesterol with recurrent cardiovascular events in statin-treated patients according to different inflammatory status

Liu, H., Li, S., Cao, Y., Guo, Y., Zhu, C., Wu, N., & Li, J. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.06.907 · Cited by 18 · see citing works

Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis

Yang, J., Wang, Y., Xi, Z., Ma, Y., Shao, C., Wang, W., & Tang, Y. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9120452 · Cited by 17 · see citing works

Impact of Ezetimibe Alone or in Addition to a Statin on Plasma PCSK9 Concentrations in Patients with Type 2 Diabetes and Hypercholesterolemia: A Pilot Study

Miyoshi, T., Nakamura, K., Doi, M., & Ito, H. (2015) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-015-0119-2 · Cited by 17 · see citing works

Association of remnant cholesterol and lipid parameters with new-onset carotid plaque in Chinese population

Liu, B., Fan, F., Zheng, B., Yang, Y., Jia, J., Sun, P., Jiang, Y., Li, K., Liu, J., Chen, C., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.903390 · Cited by 15 · see citing works

The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, parallel group trial in Japan (PROUD48 study)

Takeda, Y., Sakuma, I., Hiramitsu, S., Okada, M., Ueda, S., & Sakurai, M. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1094100 · Cited by 15 · see citing works

Echolucency of Carotid Plaque Is Useful for Assessment of Residual Cardiovascular Risk in Patients With Chronic Coronary Artery Disease Who Achieve LDL-C Goals on Statin Therapy

Uematsu, M., Nakamura, T., Sugamata, W., Kitta, Y., Fujioka, D., Saitō, Y., Kawabata, K., Obata, J., Watanabe, Y., Watanabe, K., et al. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0783 · Cited by 15 · see citing works

LDL and HDL lipoprotein subfractions in multiple sclerosis patients with decreased insulin sensitivity

Rádiková, Ž., Penesová, A., Vlček, M., Havranová, A., Siváková, M., Šiarnik, P., Žitňanová, I., Imrich, R., Kollár, B., & Turčáni, P. (2018) · Endocrine Regulations · doi:10.2478/enr-2018-0017 · Cited by 14 · see citing works

Could remnant-like particle cholesterol become a risk factor in diabetic menopausal women with coronary artery disease? A cross-sectional study of single academic center in China

Feng, X., Guo, Q., Zhou, S., Sun, T., Liu, Y., Zhou, Z., & Zhou, Y. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01224-8 · Cited by 14 · see citing works

Implications of the Mediterranean diet and physical exercise on the lipid profile of metabolically healthy obese women as measured by nuclear magnetic resonance spectroscopy ( 1 H NMR)

Rodríguez‐García, E., Ruiz-Nava, J., Santamaria-Fernández, S., Fernández‐García, J. C., Vargas‐Candela, A., Yahyaoui, R., Tinahones, F. J., Bernal-López, M. R., & Gómez-Huelgas, R. (2018) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2018.03.007 · Cited by 13 · see citing works

The Hidden Danger in Family Environment: The Role of Self-Reported Parenting Style in Cognitive and Affective Empathy Among Offenders

Wang, S., Hu, H., Wang, X., Dong, B., & Zhang, T. (2021) · Frontiers in Psychology · doi:10.3389/fpsyg.2021.588993 · Cited by 13 · see citing works

Lipid Profiles in Out-of-Hospital Sudden Unexpected Death

Hosadurg, N., Bogle, B. M., Joodi, G., Sadaf, M. I., Pursell, I. W., Mendys, P., Mounsey, J. P., & Simpson, R. J. (2018) · Mayo Clinic Proceedings Innovations Quality & Outcomes · doi:10.1016/j.mayocpiqo.2018.06.010 · Cited by 13 · see citing works

Intravascular ultrasound morphology of culprit lesions and clinical demographics in patients with acute coronary syndrome in relation to low-density lipoprotein cholesterol levels at onset

Takaoka, N., Tsujita, K., Kaikita, K., Hokimoto, S., Yamanaga, K., Komura, N., Chitose, T., Ono, T., Mizobe, M., Horio, E., et al. (2013) · Heart and Vessels · doi:10.1007/s00380-013-0401-7 · Cited by 12 · see citing works

Efficacy and Safety of Pemafibrate, a Novel Selective PPARα Modulator in Chinese Patients with Dyslipidemia: A Double-Masked, Randomized, Placebo- and Active-Controlled Comparison Trial

Dai, W., Lv, Q., Li, Q., Fu, L., Zhang, Y., Zhang, Y., Liu, L., Tanigawa, R., Kunitomi, K., Kamei, R., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.64112 · Cited by 10 · see citing works

Impact of Serum Retinol-Binding Protein 4 Levels on Regulation of Remnant-Like Particles Triglyceride in Type 2 Diabetes Mellitus

Yamaaki, N., Yagi, K., Kobayashi, J., Nohara, A., Ito, N., Asano, A., Nakano, K., Liu, J., Okamoto, T., Mori, Y., et al. (2013) · Journal of Diabetes Research · doi:10.1155/2013/143515 · Cited by 10 · see citing works

Effect of Combination Therapy of Ezetimibe and Atorvastatin on Remnant Lipoprotein Versus Double Atorvastatin Dose in Egyptian Diabetic Patients

El‐Tamalawy, M. M., Ibrahim, O. M., Hassan, T. M., & El‐Barbari, A. A. (2017) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.976 · Cited by 10 · see citing works

Clinical trials of eicosapentaenoic acid (EPA) prescription products for the treatment of hypertriglyceridemia

Doggrell, S. A. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1609942 · Cited by 11 · see citing works

Comparing remnant lipoprotein cholesterol measurement methods to evaluate efficacy of ezetimibe/statin vs statin therapy

Toth, P. P., Bays, H. E., Brown, W. V., Catapano, A. L., Davidson, M. H., Farnier, M., Tomassini, J. E., Jensen, E. H., Polis, A. B., & Tershakovec, A. M. (2019) · Journal of clinical lipidology · doi:10.1016/j.jacl.2019.09.001 · Cited by 10 · see citing works

Identification of molecular species of cholesteryl ester hydroperoxides in very low-density and intermediate-density lipoproteins

Shrestha, R., Hui, S., Sakurai, T., Yagi, A., Takahashi, Y., Takeda, S., Jin, S., Fuda, H., & Chiba, H. (2013) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563213516093 · Cited by 10 · see citing works

Improved prediction of prognosis and therapy response for lung adenocarcinoma after identification of DNA-directed RNA polymerase-associated lncRNAs

Yu, J., Lan, L., Liu, C., & Zhu, X. M. (2023) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-023-05118-x · Cited by 9 · see citing works

Omega-3 Fatty Acids Reduce Remnant-like Lipoprotein Cholesterol and Improve the Ankle–Brachial Index of Hemodialysis Patients with Dyslipidemia: A Pilot Study

Kobayashi, Y., Fujikawa, T., Haruna, A., Kawano, R., Ozawa, M., Haze, T., Komiya, S., Suzuki, S., Ohki, Y., Fujiwara, A., et al. (2023) · Medicina · doi:10.3390/medicina60010075 · Cited by 8 · see citing works

Association Between Serum Remnant Cholesterol Level and Metabolic Dysfunction-associated Steatotic Liver Histology

Miyake, T., Furukawa, S., Matsuura, B., Yoshida, O., Kanamoto, A., Miyazaki, M., Shiomi, A., Nakaguchi, H., Okazaki, Y., Nakamura, Y., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae597 · Cited by 7 · see citing works

Effects of Ezetimibe on Serum Polyunsaturated Fatty Acids in Patients With Coronary Artery Disease

Kurisu, S., Shimonaga, T., Iwasaki, T., Ishibashi, K., Mitsuba, N., Dohi, Y., & Kihara, Y. (2013) · International Heart Journal · doi:10.1536/ihj.54.254 · Cited by 7 · see citing works

Add-on Ezetimibe Reduces Small Dense Low-Density Lipoprotein Cholesterol Levels Without Affecting Absorption of Eicosapentaenoic Acid in Patients with Coronary Artery Disease: A Pilot Study

Kubo, M., Miyoshi, T., Kimura, T., Noda, Y., Kohno, K., Nakamura, K., Morita, H., & Ito, H. (2014) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-014-0082-3 · Cited by 6 · see citing works

Elevated remnant cholesterol as a potential predictor for cardiovascular events in rheumatoid arthritis patients

Chang, C., Li, Y., Chen, P., Chang, S.-H., & Chen, D. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1449219 · Cited by 5 · see citing works

Study protocol of the PROUD48 study comparing the effects of pemafibrate and omega-3 fatty acid ethyl esters on ApoB-48 in statin-treated patients with dyslipidaemia: a prospective, multicentre, open-label, randomised, parallel group trial in Japan

Takeda, Y., Sakuma, I., Hiramitsu, S., Okada, M., Ueda, S., & Sakurai, M. (2022) · BMJ Open · doi:10.1136/bmjopen-2022-061360 · Cited by 4 · see citing works

Low Remnant Cholesterol and In‐Hospital Bleeding Risk After Ischemic Stroke or Transient Ischemic Attack

Wu, Z., Zhang, H., Xu, Y., Li, X., Li, X., Balmer, L. A., Guo, X., Zhang, Q., Han, X., & Tao, L. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.034307 · Cited by 5 · see citing works

Association of triglyceride-glucose index with adverse cardiovascular events in patients with established coronary artery disease according to different inflammatory status

Lin, Z., He, J., Song, C., Yuan, S., Song, Y., Bian, X., & Dou, K. (2024) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2024.04.010 · Cited by 5 · see citing works

Comprehensive Assessment of Lipid Markers in Cardiovascular Events Prediction

Inoue, N., Morikawa, S., & Murohara, T. (2024) · International Heart Journal · doi:10.1536/ihj.24-149 · Cited by 4 · see citing works

Integrate prediction of machine learning for single ACoA rupture risk: a multicenter retrospective analysis

Li, Y., Huan, L., Lü, W., Li, J., Wang, H., Wang, B., Song, Y., Peng, C., Wang, J., Yang, X., et al. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1126640 · Cited by 4 · see citing works

The impact of remnant lipoprotein cholesterol on the prognosis of patients undergoing PCI under different glycemic states: a prospective cohort study

Ye, Z., Cui, K., Yin, D., Zhu, C., Feng, L., Xie, E., Du, Y., Yang, M., & Dou, K. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112979 · Cited by 3 · see citing works

Differences in lipid parameters among statins treated patients with coronary arteriosclerosis – a pilot study

Burchardt, P., Żurawski, J., Kubacki, T., Żuchowski, B., & Wysocki, H. (2012) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201100260 · Cited by 2 · see citing works

Modeling exposure-driven adverse events of EGFR TKIs in the treatment of patients with non-small cell lung cancer

Yong, L., Liu, Y., Jian, W.-Z., Cai, L., Bao, T.-Y., Liu, C., Gan, E.-Z., Wang, T., Luo, P.-Y., Cao, B., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01573-z · Cited by 2 · see citing works

Impact of remnant cholesterol on short-term mortality in acute decompensated heart failure: cohort study evidence from Jiangxi, China

Jian, G., Jiang, K., Lu, Z., He, S., Xie, L., Zhang, S., Wang, Q., Lu, H., Xiong, Z., Wu, Z., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1624112 · Cited by 2 · see citing works

Elevated Remnant Lipoprotein Related to Adverse Events in Patients with Chronic Limb-Threatening Ischemia after Endovascular Therapy for Below-the-Knee Lesions

Ito, N., Hishikari, K., Yoshikawa, H., Yano, H., Iiya, M., Murai, T., Hikita, H., Takahashi, A., Yonetsu, T., & Sasano, T. (2022) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2022.01.024 · Cited by 1 · see citing works

Entropy-TOPSIS-based quantitative evaluation of specific roles of the enhanced coagulation process in multi-objective sewage pre-concentration by microfiltration

Xing, Y., Zhang, X., Han, S., Ling, L., Feng, X., Zhang, X., Liu, Z., & Jin, Z. (2024) · Journal of Water Process Engineering · doi:10.1016/j.jwpe.2024.106827 · Cited by 1 · see citing works

Multidimensional lipid phenotyping for stratification of residual cardiovascular risk: A focus on fatty acid balance

Inoue, N., Imaizumi, T., Ito, Y., Morikawa, S., Murohara, T., Maekawa, Y., & Amano, T. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.04.033 · Cited by 1 · see citing works

Is metabolic dysfunction-associated fatty liver disease a protective factor in hepatocellular carcinoma patients after hepatectomy? A retrospective study based on different analysis methodsPreprint

Kong, Q., Gao, Q., Li, W., & Chen, Z. (2023) · Research Square · doi:10.21203/rs.3.rs-3327432/v1 · Cited by 1 · see citing works

Effects of Pitavastatin on Remnant-Like Lipoprotein Particle Cholesterol in Patients with Dyslipidemia: A Randomized Controlled Trial

Domori, T., SAKUMA, N., Saeki, T., Okayama, N., Hibino, T., Nagata, T., Joh, T., Suzuki, S., Yoshikawa, M., Satô, T., et al. (2012) · Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics · doi:10.3999/jscpt.43.375

Remnant Cholesterol and Ischemic Cardiovascular Disease: A Cross-Sectional Study in Northern ChinaPreprint

Liu, M., Zhang, N., Fang, X., Bao, H., Yan, T., Zhu, H., Zhao, Y., Zhang, W., Bi, Y., Tian, Z., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-1140711/v1

Genetic lipid disorders, the APOE gene and Familial Dysbetalipoproteinemia

Heidemann, B. E. (2022) · doi:10.33540/1408

Correlation of Triglyceride-Rich Lipoprotein Cholesterol and Diabetes Mellitus in Stroke Patients

Luo, R., Jiang, H., Wang, T., Xu, Y., & Qi, X. (2022) · International Journal of Endocrinology · doi:10.1155/2022/7506767

Apoproteins and Cell Surface Receptors Regulating Lipoprotein Metabolism in the Setting of Type 2 Diabetes

Dayspring, T. D., & Toth, P. P. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-26681-2_4

Remnant Cholesterol and Carotid Intraplaque Neovascularization Assessed by Contrast-Enhanced Ultrasonography in Patients With Ischemic Stroke

Song, Y., Dang, Y., Feng, J., & Ruan, L. T. (2024) · Cardiology Research · doi:10.14740/cr1634

The influence of different types of collateral vessels on the recurrence of macular edema in branch retinal vein occlusion

Zhang, Y., Zhu, W., Wu, Y., Wang, X., & Zhou, A. (2025) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-025-06911-9

Additional file 1 of The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes

Yexuan, C., Zhang, H.-W., Jin, J.-L., Liu, H.-H., Zhang, Y., Gao, Y., Guo, Y.-L., Wu, N.-Q., Hua, Q., Li, Y.-F., et al. (2020) · Figshare · doi:10.6084/m9.figshare.12618338

Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins

Raja, V., Aguiar, C. A., Alsayed, N., Chibber, Y. S., ElBadawi, H., Farnier, M., Pushpa, K., Tokgözoğlu, L. S., Zambon, A., Berrou, J., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1837004

Association of remnant cholesterol with prognosis in atherosclerotic cardiovascular disease: A systematic review and meta-analysis

Pei, Y., Liu, B., & Gu, Y. (2026) · Journal of clinical lipidology · doi:10.1016/j.jacl.2026.07.018

P1227Remnant lipoprotein is a residual risk of future cardiovascular events in patients with stable coronary artery disease and on statin LDL-cholesterol levels less than 70 mg/dl

Fujihara, Y., Nakamura, T., Horikoshi, T., Obata, J., Fujioka, D., Watanabe, Y., Watanabe, K., & Kugiyama, K. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz748.0185

Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL

Fujihara, Y., Nakamura, T., Horikoshi, T., Obata, J., Fujioka, D., Watanabe, Y., Watanabe, K., & Kugiyama, K. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0047 · Cited by 52 · see citing works

High Remnant Lipoprotein Predicts Recurrent Cardiovascular Events on Statin Treatment After Acute Coronary Syndrome

Nguyen, S. V., Nakamura, T., & Kugiyama, K. (2014) · Circulation Journal · doi:10.1253/circj.cj-14-0380 · Cited by 34 · see citing works

Lipoprotein remnants: to be or not to be

Pirillo, A., & Catapano, A. L. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab511 · Cited by 7 · see citing works

Beyond LDL-C levels, does remnant cholesterol estimation matter?

Pirillo, A., Norata, G. D., & Catapano, A. L. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487319899622 · Cited by 22 · see citing works